Publicacións en colaboración con investigadores/as de Memorial Sloan Kettering Cancer Center (2)

2022

  1. IBCL-271 Primary Efficacy and Safety Analysis of a Global Phase II Study of Zandelisib Administered by Intermittent Dosing (ID) in Patients With Relapsed or Refractory (R/R) Follicular Lymphoma (FL): The TIDAL Study

    Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, pp. S387-S388

2021

  1. COVID-19 in patients with CLL: improved survival outcomes and update on management strategies

    Blood, Vol. 138, Núm. 18, pp. 1768-1773